共 50 条
COST PER RESPONDER OF BIMEKIZUMAB AGAINST IL17A, IL-12/23 AND IL-23 INHIBITORS IN THE TREATMENT OF PSORIATIC ARTHRITIS IN SWEDEN
被引:0
|作者:
Lyris, N.
[1
]
Geale, K.
[2
,3
]
Aldven, M.
[3
]
Engstrom, A.
[4
]
Willems, D.
[5
]
机构:
[1] UCB Pharma, Slough, Berks, England
[2] Umea Univ, Dept Publ Hlth & Clin Med, Dermatol & Venerol, Umea, Sweden
[3] Quantify Res, Stockholm, Sweden
[4] UCB Pharm, Stockholm, Sweden
[5] UCB Pharm, Brussels, Belgium
关键词:
D O I:
暂无
中图分类号:
F [经济];
学科分类号:
02 ;
摘要:
EE649
引用
收藏
页码:S178 / S178
页数:1
相关论文